AQbD-Assisted Development and Validation of a Stability-Indicating and Greener HPTLC- Densitometric Method for Simultaneous Determination of Dapagliflozin and Sitagliptin in Pharmaceutical Formulations

In the vast landscape of modern medicine, the management of chronic conditions often relies on the precise combination of different drugs working in harmony. For millions of people living with type 2 diabetes, a condition where the body struggles to regulate blood sugar, doctors frequently prescribe a dual approach. One medication helps the kidneys release excess sugar through urine, while another encourages the pancreas to release insulin only when needed. To ensure these medicines are safe and effective, pharmaceutical manufacturers must rigorously test their products. This requires analytical methods capable of detecting the exact amount of each drug in a pill, while also proving that the drugs remain stable and do not break down into harmful substances over time. Traditionally, these tests have relied on complex, liquid-based machines that consume significant amounts of chemical solvents, creating a substantial environmental footprint.

A team of researchers has now developed a new way to perform these critical quality checks that is both simpler and kinder to the environment. By applying a systematic planning strategy known as Analytical Quality by Design, they created a method that uses a thin layer of silica gel on a plate, similar to a miniature race track, to separate and measure two specific diabetes drugs: dapagliflozin and sitagliptin. Instead of relying on trial and error, the scientists used a mathematical model to determine the perfect mixture of liquids needed to move the drugs along the plate at just the right speed. Their work resulted in a highly accurate technique that not only confirms the purity of the medicine but also withstands harsh conditions, proving it can detect when the drugs begin to degrade. Furthermore, this new approach uses far less chemical waste than the standard methods currently in use, offering a cleaner path forward for routine laboratory testing.

The journey began with a clear goal: to create a reliable test that could measure both drugs simultaneously in a single tablet. The researchers started by identifying the key variables that would influence how the drugs moved across the testing plate. They focused on two specific liquids, ethyl acetate and methanol, which act as the mobile phase, carrying the drug molecules along the surface. To find the ideal balance between these two liquids, they employed a Central Composite Design, a structured experimental framework that allowed them to test various combinations efficiently. Rather than changing one factor at a time, they mapped out a series of experiments that revealed how the two liquids interacted with each other to affect the movement of the drugs.

Through this systematic process, the team discovered that a specific mixture of ethyl acetate, methanol, and a small amount of formic acid produced the most consistent results. Under these optimized conditions, the two drugs traveled distinct distances on the plate, separating cleanly from one another. One drug moved to a position representing 74 percent of the total distance, while the other stopped at 31 percent. This clear separation is crucial because it allows the machine to measure each drug individually without interference from the other or from any impurities. The researchers confirmed that their mathematical predictions matched the actual results almost perfectly, validating that their planning approach had successfully identified the best possible testing environment.

Once the method was established, the team subjected it to a battery of rigorous tests to ensure it met international standards for accuracy and reliability. They demonstrated that the method could detect the drugs in very small amounts, with the ability to measure quantities as low as 52 nanograms for one drug and 557 nanograms for the other. They also proved that the results were consistent, whether the test was run multiple times on the same day or on different days by different operators. When they tested the method against known amounts of the drugs, it recovered nearly 100 percent of the substance, confirming that the technique was highly accurate. These findings established the method as a robust tool for quality control, capable of handling the demands of a busy pharmaceutical laboratory.

A critical aspect of the research was testing the stability of the drugs under stress. The researchers exposed the drugs to various harsh conditions, including strong acids, strong bases, oxidizing agents, heat, and light, to simulate what might happen if the medicine were stored improperly or degraded over time. In every scenario, the method successfully separated the intact drugs from their breakdown products. The most significant degradation occurred when the drugs were exposed to a basic, alkaline environment, but even then, the test clearly distinguished the original medicine from the damaged fragments. This ability to spot degradation products is what makes the method "stability-indicating," a vital requirement for ensuring that patients receive medicine that has not spoiled.

The researchers then applied their new method to a real-world product, a commercially available tablet containing both drugs. The analysis showed that the tablets contained the correct amount of each medication, with results falling well within the acceptable range for pharmaceutical quality. This successful application proved that the method was not just a theoretical exercise but a practical solution ready for use in manufacturing and regulatory settings. The team also took a step back to evaluate the environmental impact of their work. They compared their new technique against the traditional liquid-based method, known as RP-HPLC, using several green chemistry metrics.

The comparison revealed that the new thin-layer method was significantly more environmentally friendly. It consumed far less solvent, generated less waste, and required less energy to operate. While the traditional method scored lower on environmental assessments due to its heavy use of chemicals and waste generation, the new approach achieved a much higher score, indicating a more sustainable workflow. The researchers noted that while the method is not entirely free of chemical reagents, it represents a substantial improvement over existing practices. By reducing the volume of solvents needed and simplifying the process, the study offers a tangible way to make pharmaceutical quality control more sustainable without sacrificing precision or reliability.

Ultimately, this work demonstrates that careful planning and a focus on environmental responsibility can go hand in hand with scientific rigor. The researchers did not just find a new way to measure drugs; they found a better way to measure them. By integrating a structured design approach with green chemistry principles, they created a method that is faster, cheaper, and cleaner than the alternatives. As the pharmaceutical industry continues to seek more sustainable practices, this study provides a concrete example of how modern analytical science can evolve to meet both the needs of patient safety and the demands of environmental stewardship. The method stands as a verified, reliable tool for ensuring that diabetes medications are safe, effective, and produced with a lighter footprint on the planet.